Top news of the week: 23.12.2021.
Career And Jobs
Twin gene-editing system gives twice the efficiency
A new gene-editing technique that enables larger edits than earlier ones could create new ways to study and treat genetic diseases, such as hemophilia or Hunter syndrome.
2022 forecast: With omicron extending the pandemic, how will biopharma respond to COVID?
The omicron variant has put on hold the widely held belief that the COVID-19 pandemic would transition into an endemic in 2022. As the biopharmaceutical industry approaches the new year, ...
UK biotech firm Aptamer to float valued at £80.7m
York-based company makes synthetic antibodies for pharmaceutical firms including AstraZeneca
2022 forecast: We wish we had better news for biotech dealmaking, but omicron is coming anyway
We thought we’d finally get to see what a post-pandemic world looked like in 2022, but thanks to omicron, it seems we’re in for another round of virtual dealmaking and more.
2022 forecast: Talent war in life sciences, salary inflation in C-suite builds to 'negative feedback loop'
Biopharmas are not immune to the "Great Resignation" spurred by the pandemic, and drug developers will have to create new formulations to attract and retain talent, or at least improve ...
Benjamin Franklin Institute of Technology, Ginkgo Bioworks to Develop Biotechnology Manufacturing Associates Degree
Initiative supported through a $100,000 grant from Kargman Family Foundation BOSTON, Dec. 20, 2021 /PRNewswire/ — Benjamin Franklin Institute of Technology (BFIT), a private non-profit ...
Omega's New Fund Has $650 Million to Invest in Life Science Companies
Omega raised $650 million, which it plans to invest in life science companies in the U.S. and Europe.
Next Phase of Growing a Diverse and Talented Life Sciences Workforce
Through another challenging yet hopeful year of change and transition, MassBioEd was proud to celebrate its 20th anniversary and walk you through milestones that highlight the evolution of ...